<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Infants in NICUs undergo a variety of painful procedures </plain></SENT>
<SENT sid="1" pm="."><plain>The management of pain has become an integral part of newborn infant care with the use of both systemic and topical agents to provide <z:mp ids='MP_0004270'>analgesia</z:mp> and anesthesia for procedural pain </plain></SENT>
<SENT sid="2" pm="."><plain>Tetracaine and prilocaine-<z:chebi fb="0" ids="6456">lidocaine</z:chebi> are the 2 topical <z:chebi fb="37" ids="38867">anesthetics</z:chebi> most frequently used </plain></SENT>
<SENT sid="3" pm="."><plain>Tetracaine belongs to an <z:chebi fb="21" ids="35701">ester</z:chebi> group of <z:chebi fb="0" ids="36333">local anesthetics</z:chebi> available as a topical 4% gel (Ametop, Smith and Nephew, Canada) </plain></SENT>
<SENT sid="4" pm="."><plain>The major side effects reported when using topical <z:chebi fb="37" ids="38867">anesthetics</z:chebi> are cutaneous reactions </plain></SENT>
<SENT sid="5" pm="."><plain>There are no definite reports of systemic toxicity in the published literature </plain></SENT>
<SENT sid="6" pm="."><plain>We present a recent case of an extremely <z:hpo ids='HP_0001518'>low birth weight</z:hpo> premature infant who developed a clinically significant <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> after topical tetracaine was applied before the insertion of a peripherally inserted central catheter </plain></SENT>
<SENT sid="7" pm="."><plain>The infant had no other identifiable cause for the resulting <z:hpo ids='HP_0001662'>bradycardia</z:hpo> that occurred only after Ametop was applied </plain></SENT>
<SENT sid="8" pm="."><plain>The cardiac symptoms resolved with treatment </plain></SENT>
<SENT sid="9" pm="."><plain>This case highlights a significant potential adverse event when using topical tetracaine </plain></SENT>
</text></document>